Security · CUSIP 55414P108
MABVAX THERAPEUTICS HOLDINGS, INC.
COMMON STOCK · institutional ownership from 13F filings
13F holders
2
Shares held
217.6K
Value held
$150.0K
New / sold out
0 / 1
Added / reduced
0 / 1
net -96.0K shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q4 2015
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 197,641 | $136.0K | 0.17% |
| Geduld E E | 20,000 | $14.0K | 0.01% |
Biggest buyers
Nothing to show.
Biggest sellers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| KCM INVESTMENT ADVISORS LLC | Sold out | -50,000 | -100.0% |
| Geduld E E | Reduced | -46,000 | -69.7% |